Stockholm, December 1, 2015 — Nasdaq (Nasdaq: NDAQ) announces that the trading in Immunovia AB’s shares (short name: IMMNOV) commenced today on Nasdaq First North in Stockholm. Immunovia belongs to the health care sector and is the 84th company to be admitted to trading on Nasdaq’s Nordic markets* in 2015.
Immunovia is a health care company based in Lund, Sweden. The company’s strategy is to decipher a large amount of information in the blood and translate it into clinically useful tools, in order to diagnose complex diseases such as cancer and to do this earlier and more accurately than previously possible. Immunovia’s core technology platform, IMMray™, is based on antibody microarray analysis. The company is currently performing clinical validation studies for commercialization of IMMray™ PanCan-d, where the ambition is to become the first blood-based test for early diagnosis of cancer of the pancreas. For more information, please visit www.immunovia.com.
"Our listing on the Nasdaq First North is a major corporate milestone for our company and a confirmation to the tremendous progress we have made over the past few years," said Mats Grahn, CEO of Immunovia. "We believe that the listing on Nasdaq First North will help broaden our shareholder base, increase appeal to institutional investors, provide us with better liquidity and contribute to increasing shareholder value. We are committed to continue to execute on our clinical and corporate strategy, and commercialize IMMray™ PanCan-d for early diagnosis of pancreatic cancer. The test will allow clinicians worldwide to intervene much earlier in the course of this deadly cancer and thereby radically improve the patient survival rates."
“We welcome Immunovia to Nasdaq First North and to our family of companies” said Adam Kostyál, senior vice president and head of European listings at Nasdaq. “Immunovia will make a strong addition to our growing health care sector, and we want to congratulate the company on its listing.”
Immunovia AB has appointed Wildeco Ekonomisk Information AB as the Certified Adviser.
*Main markets and Nasdaq First North at Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm.
About Nasdaq First North
Nasdaq First North is regulated as a multilateral trading facility, operated by the different exchanges within Nasdaq Nordic (Nasdaq First North Denmark is regulated as an alternative marketplace). It does not have the legal status as an EU-regulated market. Companies at Nasdaq First North are subject to the rules of Nasdaq First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market”
Nasdaq (Nasdaq: NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,600 listed companies with a market value of over $8.8 trillion and more than 10,000 corporate clients. To learn more, visit nasdaq.com/ambition or business.nasdaq.com.
Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq OMX Copenhagen A/S, Nasdaq OMX Helsinki Ltd., Nasdaq OMX Iceland hf., Nasdaq OMX Riga, AS, Nasdaq OMX Stockholm AB, Nasdaq OMX Tallinn AS, AB Nasdaq OMX Vilnius, Nasdaq OMX Clearing AB, Nasdaq OMX Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius.
Cautionary Note Regarding Forward-Looking Statements
The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.
|Media Relations Contact:|
|Christina Malmberg Hägerstrand|
|+46 8 405 65 83|